Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jun 25, 2014

Guiding Cell Therapy Development

A comprehensive manufacturing and development plan helps guide the process, but significant hurdles to commercialization still exist.

Guiding Cell Therapy Development

Not many cell therapies make it into commercial production and even fewer have become commercially viable. [© fusebulb - Fotolia.com]

  • Creating a solid manufacturing and development plan is critical to successfully shepherding a promising cell therapy from discovery to market, but there are still ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »